Miriam Provost - Dec 13, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
VP, Global Regulatory Affairs
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Dec 13, 2023
Transactions value $
-$56,648
Form type
4
Date filed
12/15/2023, 05:31 PM
Previous filing
Sep 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $6.7K +415 +1.76% $16.14 24K Dec 13, 2023 Direct
transaction TMDX Common Stock Sale -$15.5K -206 -0.86% $75.10 23.8K Dec 13, 2023 Direct F1
transaction TMDX Common Stock Options Exercise $108K +1.63K +6.85% $66.10 25.5K Dec 13, 2023 Direct
transaction TMDX Common Stock Sale -$113K -1.51K -5.93% $75.10 23.9K Dec 13, 2023 Direct F1
transaction TMDX Common Stock Options Exercise $138K +3.6K +15.02% $38.46 27.5K Dec 13, 2023 Direct
transaction TMDX Common Stock Sale -$181K -2.41K -8.74% $75.10 25.1K Dec 13, 2023 Direct F1
transaction TMDX Common Stock Gift $0 -1.79K -7.1% $0.00 23.3K Dec 15, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -415 -5.04% $0.00 7.81K Dec 13, 2023 Common Stock 415 $16.14 Direct F4
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -1.63K -18.75% $0.00 7.07K Dec 13, 2023 Common Stock 1.63K $66.10 Direct F5
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -3.6K -31.52% $0.00 7.81K Dec 13, 2023 Common Stock 3.6K $38.46 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
F2 On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
F3 Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F4 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
F5 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023.
F6 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.